Galacto-Oligosaccharides - Prebiotics and Probiotics Ingredients - page 92

73. Schley, P.D. and Field, C.J., The immune-enhancing effects of dietary fibers and prebiot-
ics, Br. J. Nutr ., 87, S221, 2002.
74. Norin, E. and Midtvedt, T., Interactions of microflora associated characteristics of the
host; non-immune function, Micr. Ecol. Health Dis ., 11, 186, 2000.
75. Isolauri, E., Probiotics in human disease, Am. J. Clin. Nutr ., 73(6), 1142S, 2001.
76. Eiwegger, T. et al., Human milk-derived oligosaccharides and plant-derived oligosaccha-
rides stimulate cytokine production of cord blood T-cells in vitro , Pediatr. Res ., 56(4), 620,
2004.
77. Vos, A. et al., Immune-modulatory effects and potential working mechanisms of orally
applied nondigestible carbohydrates, Crit. Rev. Immunol ., 27, 97, 2007.
78. Inan M.S. et al., The luminal short-chain fatty acid butyrate modulates NF-κβ activity in
a human colonic epithelial cell line, Gastroenterology, 118, 724, 2000.
79. Yin, L., Laevsky, G., and Giardina, C., Butyrate suppression of colonocyte NF-κβ acti-
vation and cellular proteasome activity, J. Biol. Chem ., 276, 44641, 2001.
80. Cavaglieri, C.R. et al., Differential effects of short-chain fatty acids on proliferation and
production of pro- and anti-inflammatory cytokines by cultured lymphocytes, Life Sci .,
73, 1683, 2003.
81. Tedelind, S. et al., Anti-inflammatory properties of the short-chain fatty acids ace-
tate and propionate: A study with relevance to inflammatory bowel disease, World J.
Gastroenterol ., 13, 2826, 2007.
82. Vos, A.P. et al., A specific prebiotic oligosaccharide mixture stimulates delayed-type
hypersensitivity in a murine influenza vaccination model, Int. Immunopharmacol ., 6,
1277, 2006.
83. Van der Waaij, L.A., Limburg, P.C., Mesander, G., Van der Waaij, D., In vivo IgA coat-
ing of anaerobic bacteria in human faeces, Gut , 38, 348, 1996.
84. Hanson, L.Å. and Korotkova, M., The role of breastfeeding in prevention of neonatal
infection, Semin. Neonatol ., 7, 275, 2002.
85. Bakker-Zierikzee, A.M. et al., fecal sIgA secretion in infants fed on pre- or probiotic
infant formula, Pediatr. Allergy Immunol ., 17, 134, 2006.
86. Scholtens, P.A. et al., Fecal secretory immunoglobulin A is increased in healthy infants
who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-
oligosaccharides, J. Nutr ., 138(6), 1141, 2008.
87. Majamaa, H. and Isolauri, E., Probiotics: A novel approach in the management of food
allergy, J. Allergy Clin. Immunol ., 99, 179, 1997.
88. Strobel, S., Mechanisms in adverse reactions to food. Mechanisms of tolerance and
sensitization in the intestine and other organs of the body, Allergy , 50(20 Suppl.), 18,
1995.
89. Viljanen, M. et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in
infants: A double-blind placebo-controlled trial, Allergy , 60, 494, 2005.
90. Rosenfeldt, V. et al., Effect of probiotic Lactobacillus strains in children with atopic
dermatitis, J. Allergy Clin. Immunol ., 111, 389, 2003.
91. Weston, S. et al., Effects of probiotics on atopic dermatitis: A randomized controlled
trial, Arch. Dis. Child ., 90, 892, 2005.
92. Gdalevich, M. et al., Breast-feeding and the onset of atopic dermatitis in childhood: A
systematic review and meta-analysis of prospective studies, J. Am. Acad. Dermatol .,
45(4), 520, 2001.
93. Gdalevich, M., Mimouni, D., and Mimouni, M., Breast-feeding and the risk of bronchial
asthma in childhood: A systematic review with meta-analysis of prospective studies, J .
Pediatr ., 139(2), 261, 2001.